Internal Medicine, Pulmonary Disease · Detroit, MI
NPI
1841566072
Since 2012
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2799 W Grand Blvd
Detroit, MI, 48202
Phone (313) 916-2600
Groups this clinician bills Medicare through
Medicare paid, 2024
$143K
2,208 services
Medicare patients, 2024
423
Average age 77
Drug cost, 2024
$662K
1,925 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kamelia Albujoq was code G0316 (prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th), 750 times for 115 patients. In total Kamelia Albujoq billed 2,208 services in 33 codes, and Medicare paid $143K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-20.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 750 | 115 | $24.13 | $18K |
| 99292 Critical Care E&M | Facility | 338 | 89 | $86.67 | $29K |
| 99291 Critical Care E&M | Facility | 244 | 99 | $171.36 | $42K |
| 99233 Hospital E&M - Subsequent | Facility | 234 | 125 | $93.37 | $22K |
| 94010 Pulmonary Function Testing | Office | 127 | 124 | $5.77 | $733 |
| 99214 Office E&M - Established | Office | 121 | 96 | $73.38 | $8,879 |
| 94729 Pulmonary Function Testing | Office | 105 | 102 | $6.41 | $673 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 57 | 47 | $12.99 | $741 |
| 99205 Office E&M - New | Office | 47 | 47 | $142.29 | $6,688 |
| 99223 Hospital E&M - Initial | Facility | 40 | 40 | $138.22 | $5,529 |
| 94726 Pulmonary Function Testing | Office | 15 | 15 | $8.67 | $130 |
| 94010 Pulmonary Function Testing | Facility | 14 | 14 | $5.99 | $83.85 |
| 99232 Hospital E&M - Subsequent | Facility | 13 | 11 | $63.13 | $821 |
| 99222 Hospital E&M - Initial | Facility | 13 | 13 | $105.12 | $1,367 |
| 99215 Office E&M - Established | Office | 12 | 11 | $115.52 | $1,386 |
By year: 2022 $38K for 585 services; 2023 $133K for 1,642 services; 2024 $143K for 2,208 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kamelia Albujoq prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 273 prescriptions and refills. In total Kamelia Albujoq wrote 1,925 Medicare prescriptions that cost $662K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 273 | 376 | 61 | $233K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 257 | 311 | 111 | $9,463 |
| Montelukast Sodium Generic | 146 | 296 | 44 | $1,782 |
| Prednisone Generic | 133 | 162 | 69 | $549 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 124 | 184 | 39 | $28K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 114 | 146 | 22 | $89K |
| Ventolin Hfa Albuterol Sulfate | 107 | 118 | 44 | $6,623 |
| Advair Hfa Fluticasone Propion/Salmeterol | 71 | 99 | 17 | $34K |
| Fluticasone Propionate Generic | 56 | 119 | 21 | $1,289 |
| Symbicort Budesonide/Formoterol Fumarate | 54 | 86 | 20 | $19K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 53 | 95 | 21 | $19K |
| Spiriva Respimat Tiotropium Bromide | 49 | 93 | 13 | $46K |
| Tiotropium Bromide Generic | 43 | 91 | 14 | $36K |
| Incruse Ellipta Umeclidinium Bromide | 36 | 44 | Under 11 | $15K |
| Azelastine Hcl Generic | 36 | 66 | Under 11 | $759 |
Brand drugs: 1,154 claims; generic drugs: - claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kamelia Albujoq were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.